ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
Expert Discusses Challenges With Checkpoint Inhibition in the Frontline Treatment of Metastatic Bladder Cancer
8:00 PM, Wed October 2, 2019
First-Line Atezolizumab/Chemotherapy Improves Outcomes in Metastatic Urothelial Cancer
3:22 PM, Mon September 30, 2019
Investigational Mitomycin Gel Agents Demonstrate High CR Rates in Bladder Cancer Studies
1:34 PM, Thu September 26, 2019
Faced With BCG Shortages, Oncologists Move to Rationing of Care
4:48 PM, Wed September 25, 2019
Promising Durvalumab Plus Olaparib Combination Being Explored in Metastatic Urothelial Cancer
3:28 PM, Thu September 19, 2019
FDA Grants Priority Review to Enfortumab Vedotin for Advanced Urothelial Cancer
2:02 PM, Mon September 16, 2019
Expert Stresses New Technologies and Collaboration to Improve Outcomes in Genitourinary Cancers
3:24 PM, Tue September 10, 2019
Enzalutamide With Gemcitabine and Cisplatin Safely Targets AR+ Metastatic Bladder Cancer
9:00 PM, Tue August 27, 2019
